🏥 NHS vs Private
Why some pharmacies quietly restrict who they’ll prescribe Mounjaro to
You meet the NHS eligibility criteria. Your BMI qualifies. You’ve read the guidance.
You fill in the questionnaire at an online pharmacy — and you’re rejected.
The rejection message is vague:
-
❌
“Not suitable at this time” -
❌
“Clinical assessment unsuccessful” -
❌
“Unable to prescribe based on your information”
But another pharmacy approves you without issue.
This guide explains why eligibility doesn’t equal acceptance everywhere — and how to choose providers aligned with your profile.
What to check before applying to another provider
A decline from one pharmacy does not automatically mean every provider will decline you. It may reflect that provider’s own risk policy, service capacity, prescribing model, or evidence requirements.
Clinical decisions remain with the provider. The comparison task is to find a service whose process is clear enough for your situation.
Rejection ≠ judgement
Different providers have different risk tolerances and service capabilities. Being declined by one doesn’t mean you’re unsuitable — it often just means that provider’s criteria are more conservative.
Why eligibility doesn’t equal acceptance
NHS criteria define who can access Mounjaro via the NHS — but private providers aren’t bound by exactly the same rules.
The difference:
🏥 NHS eligibility criteria (guidance)
-
•
BMI ≥35 with weight-related health condition, or BMI ≥40 -
•
Type 2 diabetes (if not on insulin) -
•
Certain medical history exclusions apply
🏪 Private provider criteria (varies)
-
•
May accept lower BMI (e.g., BMI 30+, or even BMI 27+ with conditions) -
•
May have stricter criteria for certain medical histories -
•
May decline complex cases even if NHS-eligible
The key difference:
Private providers can be more flexible (accepting lower BMI) or more conservative (declining complex medical histories) than NHS criteria. There’s no single standard.
Provider risk tolerance
Prescribing is always about balancing benefit vs risk. Different providers draw that line differently.
What affects a provider’s risk tolerance:
⚖️ Prescriber experience & confidence
Newer prescribers may stick to simpler cases; experienced ones may accept more complexity
🏥 Clinical support infrastructure
Some providers have in-house GPs/endocrinologists for complex cases; others rely on single prescribers
📋 Indemnity insurance requirements
Insurers may specify what conditions/histories are acceptable to prescribe for remotely
🎯 Business model & volume
High-volume providers may standardize criteria; boutique providers may personalize more
📊 Previous adverse events
If a provider had a patient with serious side effects, they may tighten criteria going forward
None of this is about you personally — it’s about the provider’s internal policies and capabilities.
Side-effect management capacity
Some providers decline patients not because they’re unsuitable for Mounjaro, but because the provider can’t support them properly if side effects occur.
Common reasons providers decline due to support capacity:
🩺 Complex medical history requiring close monitoring
Example: History of pancreatitis, gallbladder disease, kidney issues — Mounjaro isn’t contraindicated, but requires more careful oversight than some remote services can provide
💊 Multiple medications (interaction concerns)
Example: Taking insulin, blood thinners, thyroid medication, antidepressants — not necessarily unsafe, but needs experienced prescriber review
😟 Mental health considerations
Example: Active eating disorder history, severe anxiety about side effects — Mounjaro may still be appropriate, but requires psychological support some providers can’t offer
📞 Limited aftercare capacity
Example: Provider has no out-of-hours support, only email response within 48 hours — may decline patients who need more responsive access
Why this can actually be responsible:
A provider saying “We can’t support you properly” is better than accepting you and providing inadequate care. It’s frustrating, but it’s often the safer choice.
Maintenance vs initiation policies
Some providers treat new patients and existing Mounjaro users differently.
Common policy differences:
🆕 New to Mounjaro (Stricter Criteria)
-
⚠️
More conservative BMI thresholds (e.g., BMI 32+ only, not 27+) -
⚠️
Stricter medical history exclusions (declining borderline cases) -
⚠️
May require GP letter or blood tests for certain conditions -
⚠️
Higher rejection rate (unknown patient, unknown tolerance)
🔄 Already Using Mounjaro (More Flexible)
-
Lower BMI accepted (maintenance at BMI 28-30 often okay) -
Proven tolerance (they know you handle the medication well) -
Continuity of care (easier to support existing vs new patients) -
Lower rejection rate (relationship established, history known)
What this means if you’re switching providers:
You might find that Provider B accepts you for continuation (because you’re already stable on Mounjaro) even though Provider A would have rejected you as a new patient. This is normal.
Why rejection doesn’t equal judgement
Being declined by a pharmacy can feel personal — especially around weight and health.
But it’s almost never about you — it’s about what that specific provider can safely offer.
What rejection usually means:
“Your case is more complex than we can handle remotely”
Not: “You don’t deserve treatment” — Just: “We’re not the right fit”
“Our prescribers don’t have experience with this combination”
Not: “Your medical history is bad” — Just: “Another provider may have more expertise”
“We can’t provide the level of monitoring you’d need”
Not: “You’re too high-risk” — Just: “You need more support than we offer”
“Our insurance doesn’t cover this scenario”
Not: “You’re unsuitable” — Just: “Legal/insurance restrictions apply”
What to do if rejected:
-
Don’t take it personally — It’s about provider capabilities, not your worth -
Try another provider — Different criteria, different outcome -
Ask for feedback — “Can you explain why?” may reveal useful info -
Consider in-person options — Face-to-face clinics may accept complex cases remote services can’t
How to choose providers aligned with your profile
Rather than guessing, look for signals about which providers might be a good fit.
What to look for on provider websites:
📋 Stated BMI criteria
If they say “BMI 30+” vs “BMI 35+”, you know their threshold. Lower BMI? Try providers with more flexible criteria.
🩺 Medical exclusions listed
Good providers list conditions they can’t treat (e.g., “We don’t prescribe to patients on insulin”). This helps you self-select.
👥 Prescriber expertise mentioned
“Specialist endocrinology team” vs “GP prescribers” suggests different complexity tolerance.
📞 Aftercare support detailed
“24/7 clinical support” vs “Email within 48 hours” indicates support capacity for complex cases.
🔄 Maintenance policy clarity
“We accept transfers from other providers” vs silence on the topic tells you their approach.
🔍 Compare providers by criteria, not just price
Different providers serve different patient profiles. Understanding who’s likely to accept you saves time and reduces rejection anxiety.
Compare UK Mounjaro Providers →
Note: Comparison focuses on process transparency and stated criteria — not endorsement of any specific provider.
Key takeaway
Rejection by one provider doesn’t mean you’re unsuitable — it means their criteria don’t match your profile.
Different providers have different risk tolerances, support capacities, and policies. Finding the right match is about alignment, not judgement.
Medical Disclaimer: This content explains common provider policies but does not replace medical advice. If you’re uncertain about your suitability for Mounjaro, consult your GP or an endocrinologist. Provider criteria change frequently — always verify current policies directly. This information is for educational purposes only.